FDA Relaxes Enforcement Policy On Fetal, Maternal Monitoring Devices So They Can Be Used At Home
Executive Summary
A new guidance doc from the US FDA says the agency won’t penalize manufacturers of non-invasive fetal and maternal monitoring devices if they make changes to their products so they can be used in a home setting during the COVID-19 pandemic.